These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 11294371)
1. Pharmacokinetic investigation of a nicotine sublingual tablet. Molander L; Lunell E Eur J Clin Pharmacol; 2001; 56(11):813-9. PubMed ID: 11294371 [TBL] [Abstract][Full Text] [Related]
2. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
3. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics. Bramer SL; Forbes WP Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883 [TBL] [Abstract][Full Text] [Related]
4. Bioavailability of Edaravone Sublingual Tablet Versus Intravenous Infusion in Healthy Male Volunteers. Wang J; Chen X; Yuan B; Wang W; Xu C; Zhao W; Zhao P; Wang Y; Zhao X; Wang Y Clin Ther; 2018 Oct; 40(10):1683-1691. PubMed ID: 30241688 [TBL] [Abstract][Full Text] [Related]
5. The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers. Noehr-Jensen L; Damkier P; Bidstrup TB; Pedersen RS; Nielsen F; Brosen K Eur J Clin Pharmacol; 2006 Jun; 62(6):437-45. PubMed ID: 16770647 [TBL] [Abstract][Full Text] [Related]
6. Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: a crossover study. Lunell E; Lunell M Nicotine Tob Res; 2005 Jun; 7(3):397-403. PubMed ID: 16085507 [TBL] [Abstract][Full Text] [Related]
8. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers. Darwish M; Tempero K; Kirby M; Thompson J Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093 [TBL] [Abstract][Full Text] [Related]
9. Single-dose pharmacokinetics of nicotine when given with a novel mouth spray for nicotine replacement therapy. Kraiczi H; Hansson A; Perfekt R Nicotine Tob Res; 2011 Dec; 13(12):1176-82. PubMed ID: 21849415 [TBL] [Abstract][Full Text] [Related]
11. Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: results from a single-center, single-dose, randomized, open-label crossover study in healthy adults. Greenblatt DJ; Harmatz JS; Roth T; Singh NN; Moline ML; Harris SC; Kapil RP Clin Ther; 2013 May; 35(5):604-11. PubMed ID: 23541711 [TBL] [Abstract][Full Text] [Related]
12. The effect of food on the absorption and pharmacokinetics of rivaroxaban. Stampfuss J; Kubitza D; Becka M; Mueck W Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers. DeVeaugh-Geiss AM; Chen LH; Kotler ML; Ramsay LR; Durcan MJ Clin Ther; 2010 Jun; 32(6):1140-8. PubMed ID: 20637967 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers: a randomized, open-label, 2-period, single-dose, crossover phase 1 study. Cattaneo D; Cossu MV; Fucile S; Riva A; Baldelli S; Meraviglia P; Landonio S; Impagnatiello C; Resnati C; Galli M; Clementi E; Capetti A; Rizzardini G; Gervasoni C Ther Drug Monit; 2015 Feb; 37(1):119-25. PubMed ID: 24988438 [TBL] [Abstract][Full Text] [Related]
15. Studies on the bioavailability of glyceryl trinitrate after sublingual administration of spray and tablet. Jensen KM; Mikkelsen S Arzneimittelforschung; 1997 Jun; 47(6):716-8. PubMed ID: 9239449 [TBL] [Abstract][Full Text] [Related]
16. The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers. Kamimori GH; Karyekar CS; Otterstetter R; Cox DS; Balkin TJ; Belenky GL; Eddington ND Int J Pharm; 2002 Mar; 234(1-2):159-67. PubMed ID: 11839447 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and haemodynamic effects of ISDN following different dosage forms and routes of administration. Vogt D; Trenk D; Bonn R; Jähnchen E Eur J Clin Pharmacol; 1994; 46(4):319-24. PubMed ID: 7957516 [TBL] [Abstract][Full Text] [Related]
18. Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum. Lunell E; Curvall M Nicotine Tob Res; 2011 Jul; 13(7):573-8. PubMed ID: 21454913 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and dose proportionality of fentanyl sublingual spray: a single-dose 5-way crossover study. Parikh N; Goskonda V; Chavan A; Dillaha L Clin Drug Investig; 2013 Jun; 33(6):391-400. PubMed ID: 23605506 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females. Cheng H; Leff JA; Amin R; Gertz BJ; De Smet M; Noonan N; Rogers JD; Malbecq W; Meisner D; Somers G Pharm Res; 1996 Mar; 13(3):445-8. PubMed ID: 8692739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]